Cargando…

The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults

OBJECTIVE: To clarify the preclinical stage of Alzheimer’s disease by estimating when β‐amyloid accumulation first becomes associated with changes in cognition. METHODS: Here we studied a large group (N = 4432) of cognitively unimpaired individuals who were screened for inclusion in the A4 trial (ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Insel, Philip S., Donohue, Michael C., Sperling, Reisa, Hansson, Oskar, Mattsson‐Carlgren, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261742/ https://www.ncbi.nlm.nih.gov/pubmed/32315118 http://dx.doi.org/10.1002/acn3.51048

Ejemplares similares

Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition
por: Tideman, Pontus, et al.
Publicado: (2022)

Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease
por: Insel, Philip S., et al.
Publicado: (2023)

Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults
por: Biddle, Kelsey D., et al.
Publicado: (2020)

Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults
por: Insel, Philip S., et al.
Publicado: (2021)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
por: Cullen, Nicholas C., et al.
Publicado: (2021)

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly
por: Svenningsson, Anna L., et al.
Publicado: (2019)

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
por: Insel, Philip S., et al.
Publicado: (2016)

Cognitive effects of Lewy body pathology in clinically unimpaired individuals
por: Palmqvist, Sebastian, et al.
Publicado: (2023)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
por: Cullen, Nicholas C., et al.
Publicado: (2021)

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
por: Insel, Philip S., et al.
Publicado: (2017)

The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population
por: Wang, Jin, et al.
Publicado: (2022)

Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly
por: Hahn, Andreas, et al.
Publicado: (2019)

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
por: Ossenkoppele, Rik, et al.
Publicado: (2019)

Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021)

Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
por: Pereira, Joana B, et al.
Publicado: (2021)

β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
por: Kumar, Atul, et al.
Publicado: (2022)

Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults
por: Vannini, Patrizia, et al.
Publicado: (2019)

Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
por: Largent, Emily A., et al.
Publicado: (2020)

Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
por: Ryan, Mary M., et al.
Publicado: (2021)

Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer’s disease
por: Cullen, Nicholas C, et al.
Publicado: (2023)

Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE ϵ4 carriers
por: Spotorno, Nicola, et al.
Publicado: (2022)

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
por: Kumar, Atul, et al.
Publicado: (2021)

Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study
por: Marshall, Gad A., et al.
Publicado: (2020)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
por: Cullen, Nicholas C., et al.
Publicado: (2020)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
por: Collij, Lyduine E., et al.
Publicado: (2021)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Physical activity is associated with increased resting‐state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults
por: Pruzin, Jeremy J., et al.
Publicado: (2022)

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
por: Palmqvist, Sebastian, et al.
Publicado: (2016)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)

GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults
por: Quevenco, F.C., et al.
Publicado: (2019)

APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
por: Brugulat-Serrat, Anna, et al.
Publicado: (2023)

Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals
por: Kang, Sung Hoon, et al.
Publicado: (2023)

Classification and prediction of cognitive trajectories of cognitively unimpaired individuals
por: Kim, Young Ju, et al.
Publicado: (2023)

Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults
por: Aslanyan, Vahan, et al.
Publicado: (2023)

Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94
por: Michalowska, Malgorzata M., et al.
Publicado: (2022)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cl11097qaulb6r9nrg96atj2c